FDA making us sweat

Botanix Pharmaceuticals Limited (ASX:BOT) is a Perth-based company. Its main asset is Sofpironium Bromide (SOFDRA), which it aims to use as a treatment for Primary Axillary Hyperhidrosis (PAH). It does have two other programs that have completed a Phase 1/2 trial; however, they are on hold until the commercialisation of Sofpironium Bromide. Sofpironium Bromide, orContinue reading “FDA making us sweat”

Oh my, I really hope this passes the trial and rises.

LTR Pharmaceutical (ASX: LTP) This is not a report or recommendation. Do whatever you want and do your own research. This is the summary of my research for the Stock LTR Pharma.  LTR Pharma (LTR) is a Brisbane-based pharmaceutical company that was listed on December 11, 2023, at 20 cents. The company is working onContinue reading “Oh my, I really hope this passes the trial and rises.”